Form 8-K ARGOS THERAPEUTICS INC For: Aug 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Argos Therapeutics, Inc. (ARGS) Posts Q2 Loss of 61c/Share
August 13, 2014 4:50 PM EDTArgos Therapeutics, Inc. (NASDAQ: ARGS) reported Q2 EPS of ($0.61), $0.01 worse than the analyst estimate of ($0.60). Revenue for the quarter came in at $1.26 million versus the consensus estimate of $1.27 million.
For earnings history and earnings-related data on Argos Therapeutics, Inc. (ARGS) click here.
... More